N/A
Completed N=743
A Web-based Bystander Education Program
Source: ClinicalTrials.gov NCT01903876 ↗Enrolled (actual)
743
Serious AEs
0.0%
Results posted
Jul 2014
Primary outcomePrimary: Prosocial Intervening Behavior — 72.2; 81.1 percent score on a scale — p=.044
Summary
This is a study to determine whether a theoretically-driven web-based 3-hour intervention designed for male college students called RealConsent is effective in increasing prosocial intervening behaviors and in preventing sexual violence perpetration. Sexual violence programs for this population have been implemented for decades in the United States, but a program that is web-based and incorporates the bystander education model has never been implemented or tested. In this study, male college students will be recruited online, enrolled and randomly assigned to RealConsent or to a comparison condition. Prior to the intervention, investigators will ask questions about their intervening and sexually coercive behaviors and other theoretical and empirical factors related to the study outcomes. Investigators will survey the young men again at post-intervention, and at 6-months follow-up to determine whether young men in the RealConsent program intervened more often and engaged in less sexual violence compared to young men in the comparison condition. The main hypotheses are: (1) college men in the RealConsent program will report more instances of prosocial intervening; and (2) college men in the RealConsent program will report less sexual violence against women.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Prosocial Intervening Behavior |
72.2; 81.1 | .044 sig |
| SECONDARY Sexual Violence Perpetration |
.498; .258 | .042 sig |
Eligibility Criteria
Inclusion Criteria
- Student matriculated at Georgia State University
- Male
- 18 to 24
- Undergraduate
- Self-identify as heterosexual or bisexual
Exclusion Criteria
- Graduate student
- Self-identify as homosexual
Data sourced from ClinicalTrials.gov (NCT01903876). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.